Log In
BCIQ
Print this Print this
 

Cenerimod

  Manage Alerts
Collapse Summary General Information
Company Actelion Ltd.
DescriptionSphingosine 1-phosphate (S1P) receptor modulator
Molecular Target Sphingosine 1-phosphate (S1P) receptor
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today